Tax & Penalty2 Oct 2026, 09:30 pm
Emcure Pharma Penalized ₹57.7 Cr by Income-Tax Dept
AI Summary
Emcure Pharmaceuticals Limited has received orders from the Income-tax Department imposing an aggregate penalty of ₹57,73,96,732 for the financial years 2014-15 to 2020-21. The company is currently evaluating legal remedies, including filing an appeal. This penalty relates to ongoing litigations previously disclosed by the company. The opposing party is the Deputy Commissioner of Income Tax, Central Circle (1)- Pune. The litigation was initiated on December 27, 2023.
Key Highlights
- Emcure Pharmaceuticals faces ₹57.7 Cr penalty from Income-tax Department.
- Penalties cover financial years 2014-15 to 2020-21.
- Company is exploring legal remedies, including appeals.
- Litigation initiated on December 27, 2023.
- Opposing party is Deputy Commissioner of Income Tax, Pune.
Price Impact
More from EMCURE